Embolism venous and Hyperkalemia

Summary:

Hyperkalemia is found among people with Embolism venous, especially for people who are male, 60+ old.

The study analyzes which people have Hyperkalemia with Embolism venous. It is created by eHealthMe based on reports of 17 people who have Embolism venous from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Embolism venous?

Embolism venous (embolus may pass into the arterial system) is found to be associated with 302 drugs and 394 conditions by eHealthMe. Check the latest studies of Embolism venous.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,951 drugs and 2,942 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

17 people who have Embolism Venous and Hyperkalemia are studied.

Would you have Hyperkalemia when you have Embolism venous?

Gender of people who have Embolism Venous and experienced Hyperkalemia *:

female: 30.77 %
male: 69.23 %

Age of people who have Embolism Venous and experienced Hyperkalemia *:

Common co-existing conditions for these people *:

High Blood Pressure: 3 people, 17.65%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 17.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
Renal Cell Carcinoma (a kidney cancer): 2 people, 11.76%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 11.76%
Ill-Defined Disorder: 2 people, 11.76%
Nausea (feeling of having an urge to vomit): 2 people, 11.76%
Constipation: 1 person, 5.88%
Fluid Overload (too much fluid in the blood): 1 person, 5.88%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Dyspnea (difficult or laboured breathing): 4 people, 23.53%
Weakness: 3 people, 17.65%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 17.65%
High Blood Pressure: 2 people, 11.76%
Hypovolaemic Shock (shock caused by severe blood or fluid loss): 2 people, 11.76%
Oedema Peripheral (superficial swelling): 2 people, 11.76%
Oxygen Saturation Decreased: 2 people, 11.76%
Pain: 2 people, 11.76%
Hemiplegia (paralysis of one side of the body): 2 people, 11.76%
Diplopia (double vision): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Embolism venous (12,049 reports)
Hyperkalemia (78,085 reports)

All the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,951 drugs)

All the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,942 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hyperkalemia and Embolism venous, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.